Bicycle Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Bicycle Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 87% to $26,976,000. Profit margin reached -670%. Total operating expenses were $216,922,000.
Profit Margin
| 2017 | 2.06M | -16.25M | -789.27% |
|---|---|---|---|
| 2018 | 7.13M | -21.84M | -306.14% |
| 2019 | 13.80M | -30.60M | -221.78% |
| 2020 | 10.39M | -51.01M | -490.95% |
| 2021 | 11.69M | -66.81M | -571.25% |
| 2022 | 14.46M | -112.71M | -779.35% |
| 2023 | 26.97M | -180.66M | -669.72% |
BCYC Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 26.97M | 14.46M | 11.69M | 10.39M | 13.80M | 7.13M | 2.06M |
Cost of revenue | 6.46M | 3.68M | 44.88M | 33.14M | 25.54M | 0 | 11.86M |
Gross profit | 20.50M | 10.77M | -33.18M | -22.75M | -11.73M | 7.13M | -9.80M |
Operating exp. | |||||||
Research and development | 156.49M | 81.60M | 44.88M | 33.14M | 25.54M | 20.76M | 11.86M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 216.92M | 131.11M | 77.31M | 62.35M | 40.1M | 28.88M | 18.27M |
Operating income | -189.94M | -116.65M | -65.61M | -51.96M | -26.29M | -21.74M | -16.21M |
Other income (expenses), net | 10.73M | 2.41M | -2.86M | 226K | -4.56M | -665K | -69K |
Income before tax | -179.20M | -114.24M | -68.48M | -51.73M | -30.86M | -22.24M | -16.28M |
Income tax expense | 1.45M | -1.52M | -1.66M | -724K | -254K | -396K | -23K |
Net income | -180.66M | -112.71M | -66.81M | -51.01M | -30.60M | -21.84M | -16.25M |
Earnings per share | |||||||
Basic EPS | -5.08 | -3.8 | -2.67 | -2.66 | -2.77 | -1.64 | -1.22 |
Diluted EPS | -5.08 | -3.8 | -2.67 | -2.66 | -2.77 | -1.64 | -1.22 |
| Data source | Data source | Data source | Data source | Data source |